Solid Biosciences Inc.
SLDB
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Solid Biosciences Inc. is a clinical-stage biotechnology company developing gene therapies for Duchenne muscular dystrophy. Its core research and development activities require animal testing to advance its lead therapeutic candidates through preclinical studies and regulatory approval processes. The company’s public filings acknowledge that its operations are subject to the Animal Welfare Act and other regulations governing the use of animals in research.
Cruelty Free Investing lists the company for exploiting animals due to its reliance on animal testing for medical research. As a biotech firm with no marketed products, its entire pipeline depends on preclinical data generated from animal models to support investigational new drug applications with the FDA. This use of animals is central to its business model and regulatory pathway.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.